Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer

Primary location

Xijing Hospital Affiliated to Air Force Military Medical University

Xi'an, Shannxi Province, China

Contact

Ting Wang, PhD